Ultrix
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ultrix, covering 2022-01-06 to 2022-01-06. Get the full timeline:
Most recent: Clinical Trial Update: The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old [Phase 3]